Please use this identifier to cite or link to this item:
|Title:||Serum CA 125 combined with transvaginal ultrasonography for ovarian cancer screening||Authors:||Roupa, Zoi
Ardavanis, Alexandros S.
|Keywords:||Serum CA 125
|Issue Date:||2004||Publisher:||International Institute of Anticancer Research||Source:||In Vivo, Vol.18, no.6, pp.831-836||Abstract:||Background: The aim of this study was to evaluate the combination of serum CA125 and Transvaginal Ultra Sonography (TVUS) score, as a screening procedure for ovarian cancer in premenopausal and postmenopausal women. Patients and Methods: A retrospective case-control pilot study was conducted. The files of 120 women with ovarian neoplasia detected by TVUS and increased CA125 level, within the framework of a prevention program, were reviewed. The relationship between the above tests and epithelial malignancy was investigated using the SPSS-12 program for Windows. Results: The combination of CA125 value exceeding 30U/ml and a TVUS score ≥35 had a sensitivity of 81.7% and specificity of 100% in predicting ovarian cancer. Mathematical analysis of the logistic model of our variables revealed a mathematical model that can calculate the likelihood of ovarian cancer detection, by using a combination of CA125≥30U/ml and TVUS score≥35. Conclusion: By combining TVUS and CA125, an accurate prediction for the presence of ovarian cancer may be achieved. Further investigation in a larger population is warranted.||Description:||Print issue issn: 0258-851X.||URI:||http://ktisis.cut.ac.cy/handle/10488/266||ISSN:||1791-7549||Rights:||International Institute of Anticancer Research|
|Appears in Collections:||Άρθρα/Articles|
Show full item record
checked on Jan 20, 2017
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.